Overview


According to FutureWise analysis the market for cancer screening  is expected to register a CAGR of 9.50% from 2024-2032.

Cancer screening is a test that can aid in the early detection of cancer before symptoms occur.It reduces the danger of malignant cells growing abnormally and lowers the risk of death. Each type of cancer has its own screening test that can help spot cancer early on. Cancer screening is a medical process aimed at detecting cancer before any major symptoms appear. Cancer screening tests are used to diagnose cancer in the body and thereby limit the number of people who get disease or reach the later stages of cancer, when treatment is no longer possible. There are screening tests for several types of cancers that are specific to that malignancy. These tests can aid in the early detection of cancer, when it is more treatable. Screening can discover cancer at an early stage, allowing treatment to begin sooner rather than later, lowering the risk of mortality. The rising number of cancer-related deaths is propelling the industry forward. Increased research and development to develop effective cancer treatments and early detection is moving the industry forward. Innovative technologies including positron emission mammography, spectroscopy-enhanced colonoscopy, and hyperpolarisation MRI, among others, are improving screening efficiency and, as a result, assisting the industry's growth.

FutureWise Market Research has instantiated a report that provides an intricate analysis of Cancer Screening Market trends that shall affect the overall market growth. Furthermore, it includes detailed information on the graph of profitability, SWOT analysis, market share and regional proliferation of this business. Moreover, the report offers insights on the current stature of prominent market players in the competitive landscape analysis of this market.

According to the research study conducted by FutureWise research analysts, the Cancer Screening Market is anticipated to attain substantial growth by the end of the forecast period. The report explains that this business is predicted to register a noteworthy growth rate over the forecast period. This report provides crucial information pertaining to the total valuation that is presently held by this industry and it also lists the segmentation of the market along with the growth opportunities present across this business vertical.

  • DiaSorin S.p.A.
  • Epigenomics AG
  • Techlab, Inc.
  • Positive Biosciences Limited
  • MedGenome Labs Ltd.
  • 20/20 GeneSystems

(Note: The list of the major players will be updated with the latest market scenario and trends)

By Cancer Type

  • Lung Cancer
  • Blood Cancer
  • Bone Cancer
  • Gall Bladder Cancer
  • Testicular Cancer
  • Thyroid Cancer
  • Breast Cancer
  • Others

By Techniques

  • Imaging Techniques
    • CT Scan
    • MRI
    • Others
  • Endoscopy
    • Colonoscopy
    • Sigmoidoscopy
    • Others
  • Biopsy and Cytology Tests
    • Needle Biopsy
    • CT-Guided Biopsy
    • Others
  • Genomic and Molecular tests
    • Next Generation Sequencing (NGS)
    • RT- PCR
    • Others

By Stages

  • TNM Stages
  • Stages 0, 1, 2, 3, 4
  • Prognostic Factors
  • Others

By Gender

  • Men
  • Women

By Region

  • North America
  • Europe
  • Asia-Pacific
  • Latin America
  • Middle East and Africa

  • Tier 1 players- established companies in the market with a major market share
  • Tier 2 players
  • Emerging players which are growing rapidly
  • New Entrants

  • Growth prospects
  • SWOT analysis
  • Key trends
  • Key data-points affecting market growth

  • To provide with an exhaustive analysis on the Cancer Screening Market By Cancer Type, By Techniques, By Stages, By Gender and By Region.
  • To cater comprehensive information on factors impacting market growth (drivers, restraints, opportunities, and industry-specific restraints)
  • To evaluate and forecast micro-markets and the overall market
  • To predict the market size, in key regions— North America, Europe, Asia Pacific, Latin America and Middle East and Africa.
  • To record and evaluate competitive landscape mapping- product launches, technological advancements, mergers and expansions

  • We have a flexible delivery model and you can suggest changes in the scope/table of content as per your requirement
  • The customization Mobility Care offered are free of charge with purchase of any license of the report
  • You can directly share your requirements/changes to the current table of content to: sales@futurewiseresearch.com

Table of Contents


  • 1.   Market Introduction
    •   1. Objectives of the Study
        2. Market Definition
        3. Market Scope
         3.1. Years Considered for the Study
         3.2. Market Covered
        4. Currency
        5. Limitations
        6. Stakeholders
  • 2.   Research Methodology
    •   1. Research Data
         1.1. Secondary Data
          1.1.1. Key Data from Secondary Sources
         1.2. Primary Data
          1.2.1. Key Data from Primary Sources
        2. Market Size Estimation
        3. Market Breakdown and Data Triangulation
        4. Assumptions for the Study
  • 3.   Executive Summary
    •   1. Market Outlook
        2. Segment Outlook
        3. Competitive Insights
  • 4.   Cancer Screening Market Variables, Trends and Scope

    •   1. Market Lineage Outlook
        2. Penetration and Growth Prospect Mapping
        3. Industry Value Chain Analysis
        4. Cost Analysis Breakdown
        5. Technology Overview
        6. Regulatory Framework
         6.1. Reimbursement Framework
         6.2. Standards and Compliances

  • 5.   Market Overview
    •   1. Market Dynamics
         1.1. Market Driver Analysis
          1.1.1. Increasing focus of Cancer Screening Market Companies on Brand Protection
          1.1.2. Untapped Opportunities in Emerging Regions
         1.2. Market Restraint Analysis
          1.2.1. High Cost Associated with Implementation of Predictive Analysis
         1.3. Industry Challenges
          1.3.1. Presence of Ambiguous Regulatory Framework
  • 6.   Cancer Screening Market Analysis Tools
    •   1. Industry Analysis - Porter’s
         1.1. Supplier Power
         1.2. Buyer Power
         1.3. Substitution Threat
         1.4. Threat from New Entrants
         1.5. Competitive Rivalry
        2. Pestel Analysis
         2.1. Political Landscape
         2.2. Environmental Landscape
         2.3. Social Landscape
         2.4. Technology Landscape
         2.5. Legal Landscape
        3. Major Deals And Strategic Alliances Analysis
         3.1. Joint Ventures
         3.2. Mergers and Acquisitions
         3.3. Licensing and Partnership
         3.4. Technology Collaborations
         3.5. Strategic Divestments
        4. Market Entry Strategies
        5. Case Studies
  • 7.   Cancer Screening Market, By Cancer Type Historical Analysis and Forecast 2024-2032 (USD Million)

    •   1. Lung Cancer
        2. Blood Cancer
        3. Bone Cancer
        4. Gall Bladder Cancer
        5. Testicular Cancer
        6. Thyroid Cancer
        7. Breast Cancer
        8. Others

  • 8.   Cancer Screening Market, By Techniques Historical Analysis and Forecast 2024-2032 (USD Million)

    •   1. Imaging Techniques
         1.1. CT Scan
         1.2. MRI
         1.3. Others
        2. Endoscopy
         2.1. Colonoscopy
         2.2. Sigmoidoscopy
         2.3. Others
        3. Biopsy and Cytology Tests
         3.1. Needle Biopsy
         3.2. CT-Guided Biopsy
         3.3. Others
        4. Genomic and Molecular tests
         4.1. Next Generation Sequencing (NGS)
         4.2. RT- PCR
         4.3. Others

  • 9.   Cancer Screening Market, By Stages Historical Analysis and Forecast 2024-2032 (USD Million)

    •   1. TNM Stages
        2. Stages 0, 1, 2, 3, 4
        3. Prognostic Factors
        4. Others

  • 10.   Cancer Screening Market, By Gender Historical Analysis and Forecast 2024-2032 (USD Million)

    •   1. Men
        2. Women

  • 11.   North America Cancer Screening Market Analysis 2018-2023 and Forecast 2024-2032 (USD Million)

    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2018-2023
         2.1. U.S.A
         2.2. Canada
         2.3. Mexico
        3. Market Size (USD Million) Forecast for North America 2024-2032

  • 12.   Latin America Cancer Screening Market Analysis 2018-2023 and Forecast 2024-2032 (USD Million)

    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2018-2023
         2.1. Brazil
         2.2. Venezuela
         2.3. Argentina
         2.4. Rest of Latin America
        3. Market Size (USD Million) Forecast for Latin America 2024-2032

  • 13.   Europe Cancer Screening Market Analysis 2018-2023 and Forecast 2024-2032 (USD Million)

    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2018-2023
         2.1. Germany
         2.2. U.K
         2.3. France
         2.4. Italy
         2.5. Spain
         2.6. Russia
         2.7. Poland
         2.8. Rest of Europe
        3. Market Size (USD Million) Forecast for Europe 2024-2032

  • 14.   Asia Pacific Cancer Screening Market Analysis 2018-2023 and Forecast 2024-2032 (USD Million)

    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2018-2023
         2.1. Japan
         2.2. China
         2.3. India
         2.4. Australia and New Zealand
         2.5. ASEAN
         2.6. Rest of Asia Pacific
        3. Market Size (USD Million) Forecast for Asia Pacific 2024-2032

  • 15.   Middle East and Africa Cancer Screening Market Analysis 2018-2023 and Forecast 2024-2032 (USD Million)

    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2018-2023
         2.1. GCC
         2.2. Israel
         2.3. South Africa
         2.4. Rest of MEA
        3. Market Size (USD Million) Forecast for MEA 2024-2032

  • 16.   Market Share Analysis and Competitive Landscape
    •   1. Global Landscape - Key Players, Revenue and Presence
        2. Global Share Analysis - Key Players (Tier 1, Tier 2, Tier 3)
        3. Global Emerging Companies
        4. North America - Market Share Analysis and Key Regional Players
        5. Europe - Market Share Analysis and Key Regional Players
        6. Asia Pacific - Market Share Analysis and Key Regional Players
        7. Global Key Player - Growth Matrix
  • 17.   Company Profiles (Competition Dashboard, Competitors Deep Dive, Products Offered and Financial Layouts)

    •   1. DiaSorin S.p.A.
         1.1. Company Overview
         1.2. Product Portfolio
         1.3. SWOT Analysis
         1.4. Financial Overview
         1.5. Strategic Overview
        2. Epigenomics AG
         2.1. Company Overview
         2.2. Product Portfolio
         2.3. SWOT Analysis
         2.4. Financial Overview
         2.5. Strategic Overview
        3. Techlab, Inc.
         3.1. Company Overview
         3.2. Product Portfolio
         3.3. SWOT Analysis
         3.4. Financial Overview
         3.5. Strategic Overview
        4. Positive Biosciences Limited
         4.1. Company Overview
         4.2. Product Portfolio
         4.3. SWOT Analysis
         4.4. Financial Overview
         4.5. Strategic Overview
        5. MedGenome Labs Ltd.
         5.1. Company Overview
         5.2. Product Portfolio
         5.3. SWOT Analysis
         5.4. Financial Overview
         5.5. Strategic Overview
        6. 20/20 GeneSystems
         6.1. Company Overview
         6.2. Product Portfolio
         6.3. SWOT Analysis
         6.4. Financial Overview
         6.5. Strategic Overview

  • 18.   Pre and Post COVID-19 Impact
    •   1. Positive influence on the healthcare industry
        2. The financial disruption of the manufacturing sector
        3. Impact of COVID-19 on emerging companies
        4. Significant mandates in the healthcare regulations initiated by administrations
        5. The overall economic slowdown of the developing and developed nations
  • 19.   FutureWise SME Key Takeaway Points for Client

Ask for Discount
Buy Now
Customize This Report
  • We Offer Special Discounts for start-ups, NGOs, and Educational & Research institutions.

Need Assistance

  • UK : +44 141 628 9353
  • US : +1 347 709 4931

What you get

  • Excel Dataset
  • Market Overview
  • Infographics
  • PowerPoint Presentation
  • PDF Report

What's included

  • Consumer Perception and Procurement
  • Market Data Forecast
  • Competitive Analysis
  • Risks and Opportunity Assessment
  • Market Trends and Dynamics
Partner

Our Clients

image0
image1
image2
image3
image4
image5
image6
image7
image8
image9
image10
image11
image11
image11
image11
image11
image11
image11
image11
image11
image11
image11
image11
image11
image11
image11